Showing results (101-110 of 108) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Neuropsychiatric Disease and Treatment|May 23, 2023
Automatic Thoughts, Self-Stigma, and Resilience Among Schizophrenia Patients with Metabolic Syndrome: A Cross-Sectional StudyShenglan Ma, Peijun Ju, Qingrong Xia, et al.Plastic and Reconstructive Surgery|November 26, 2024
Science or Spectacle? A Critical Evaluation of the Decade of Aesthetic Medicine Conferences Using the Punctuated Equilibrium FrameworkEqram Rahman, Karim Sayed, Parinitha Rao, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 26, 2024
Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: An independent validation and meta-analysisJunwei Yan, Qingrong Xia, Xuejun Sun, et al.Psychopharmacology|November 21, 2018
Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophreniaFang Yang, Keming Wang, Xiangdong Du, et al.Plastic and Reconstructive Surgery. Global Open|August 26, 2024
Intradermal Botulinum Toxin A on Skin Quality and Facial Rejuvenation: A Systematic Review and Meta-analysisEqram Rahman, Parinitha Rao, Wolfgang Philipp-Dormston, et al.Communications Medicine|April 21, 2026
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 studyXiaohua Wu, Danbo Wang, Jing Wang, et al.Journal of Hematology & Oncology|November 12, 2024
Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trialFeng Bi, Jian Dong, Chuan Jin, et al.Nature Communications|December 21, 2025
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trialXiaohua Wu, Jing Wang, Danbo Wang, et al.Pageof 11